Logos Global Management LP Passage Bio, Inc. Transaction History

Logos Global Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.24 - $10.2 $780,062 - $1.28 Million	-125,010 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.24 - $29.83 $3.56 Million - $6.55 Million	-219,428 Reduced 63.71%	125,010 $2.19 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $36.07 $3.78 Million - $9.34 Million	-258,900 Reduced 42.91%	344,438 $8.47 Million
Q1 2020 May 15, 2020	BUY	$8.86 - $22.2 $5.35 Million - $13.4 Million	603,338 New	603,338 $8.96 Million

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $55M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.